Biography:
Nawris Alhassan is a healthcare professional based in the United States. She volunteers at a free health clinic, and has observed significant gaps in care for older adults with diabetes. These experiences inspired her research on the risk of cognitive impairment in adults aged 60 and older treated with SGLT-2 inhibitors versus DPP-4 inhibitors. She finds healthcare deeply rewarding and plans to pursue further medical training with a focus on clinical research and advancing community health equity.
Title : Cognitive impairment risk in adults 60 years or older treated with SGLT-2 versus DPP-4 inhibitors